ReviewJournal of Korean medical science2026
Large Language Models and the Future of Peer-Reviewed Medical Publishing: Challenges, Editorial Responses, and a Framework for Responsible Integration.
Review in Journal of Korean medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Authors, reviewers, editors… smitten and bitten by the artificial intelligence (AI) bug!Indian journal of anaesthesia · 2026Article
- Comprehensive Consideration of Ethics in AI-assisted Scientific Writing and Peer Review.Journal of Korean medical science · 2026Review
- Toward Structured Transparency: A Governance Framework for AI Use in Biomedical Publishing.Journal of Korean medical science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The public release of large language models (LLMs) in late 2022 has fundamentally altered the landscape of scholarly medical publishing. LLMs now permeate every stage of the academic publishing pipeline, from manuscript drafting and peer review to editorial decision-making, with evidence suggesting that at least 13.5% of biomedical abstracts published in 2024 showed detectable LLM involvement. This rapid adoption has intersected with pre-existing structural vulnerabilities, including escalating article processing charges, publish-or-perish incentives, a chronic peer reviewer shortage, and inadequate editorial resources, creating interconnected challenges that affect all stakeholders. The response from the scholarly publishing community has been substantial but fragmented. International standards bodies, such as the International Committee of Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), World Association of Medical Editors (WAME), have established consensus principles prohibiting AI authorship and requiring disclosure, yet individual journals range from restrictive to actively encouraging in their AI policies, and detection-based enforcement approaches have proven fundamentally unreliable, with documented biases against non-native English speakers. This narrative review characterizes the structural challenges of LLM adoption in medical publishing, provides a systematic comparison of editorial policies across major medical journals and publishers, and examines the limitations of current detection and enforcement mechanisms. Rather than focusing on prohibition and policing, the review proposes a forward-looking framework centered on three concrete proposals: 1) a three-tiered disclosure system (assistive, augmentative, substantive) integrated with the CRediT taxonomy; 2) a four-stage artificial intelligence co-editor model for deploying LLM-based tools within editorial workflows under transparent governance principles; and 3) equity-conscious policy design with international coordination through a proposed global editorial summit. The framework aims to shift the editorial paradigm from reactive enforcement to proactive governance, addressing the operational reality that editors are overburdened and underresourced for the expanding expectations placed upon them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.